News and Press Releases
April 2026-Addgene Reinforces Its Expanding Role in Research with New Brand
Marked by decades of scientific partnership, Addgene’s evolution from a pioneering plasmid repository to a trusted resource spanning all stages of research drives refreshed brand.
March 2026-Addgene and Plasmidsaurus Announce Strategic Partnership to Scale Sequencing for Leading Plasmid Repository
Strategic partnership with Plasmidsaurus will ensure delivery of scalable, cost-effective, and reliable plasmid sequencing as Addgene’s repository expands.
February 2026-Addgene Appoints Greg Crescenzi as Vice President of Global Commercial Strategy and Partnerships
Crescenzi will play a critical role in driving Addgene's business development efforts and executing a mission-aligned commercial strategy. Learn more about our new VP of Global Commercial Strategy and Partnerships.
July 2025-Addgene Announces Strategic Partnership with Promega to Launch Plasmid Collection
Addgene’s Promega Plasmid Collection to provide industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular biology. Learn more about our strategic partnership with Promega.
April 2025-Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
Strategic appointments to Addgene’s leadership team and Board support Addgene’s growth strategy and illustrate its responsiveness to the evolving needs of the life sciences community. Learn more about our new members of the Management Team and Board of Directors.
January 2025-Addgene Expands Viral Vector Service with Packaged on Request
Viral vector service expansion empowers scientists by offering high-quality research reagents through on-demand AAV production from Addgene’s vast plasmid repository.
December 2024-Addgene Announces Nature Protocols Publication of Open Science Platform Leveraging the Organization’s Antibody Catalog to Characterize Research Antibodies
Addgene supports the antibody characterization platform developed by YCharOS (Antibody Characterization through Open Science). For any given protein target, YCharOS compares all commercially available antibodies from its industry partners in unbiased, side-by-side testing across key applications such as western blot, immunoprecipitation, and immunofluorescence.
September 2024-Twenty Years of Addgene Featured in Nature
As the non-profit plasmid repository celebrates two decades, Nature looks at the stories behind some of Addgene’s most requested DNA tools .
June 2023-The Institute for Protein Innovation and Addgene Partner to Accelerate Biomedical Discovery
The partnership between the Institute for Protein Innovation and Addgene will provide researchers with access to well-validated antibodies and other reagents — and expertise about where and how to use them.
April 2022-Addgene Appoints Dr. Chonnettia Jones as Executive Director
Starting May 2022, Dr. Jones will lead Addgene into its third decade of contributing to innovations in life science research. Learn more about our new Executive Director.
March 2022-Addgene Launches Open Access Recombinant Antibody Resource for the Scientific Research Community
Addgene now produces and distributes ready-to-use recombinant antibodies. The inaugural collection of monoclonal antibodies is part of the Neuroscience AntiBody Open Resource (NABOR), a platform that provides open access to recombinant antibodies and affinity reagents for the neuroscience community.
May 2021-Addgene Receives NIH BRAIN Initiative Grant to Create Open-Access Recombinant Antibody Resource
The Neuroscience AntiBody Open Resource (NABOR) will provide access to ready-to-use antibodies, validation of antibodies through QC and crowdsourced data, and educational resources for recombinant antibody tools. Learn more about the NIH Brain Initiative grant to create an open-access recombinant antibody resource.